Reduction of SynGAP-γ, disrupted splicing of , and oligodendrocyte deficits in mice, a genetic model of schizophrenia and neurodevelopmental disorder

Sameer Aryal,Chuhan Geng,Min Jee Kwon,Zohreh Farsi,Nathaniel Goble,Ahmet S. Asan,Kira Brenner,Nate Shepard,Olivia Seidel,Yining Wang,Ally Nicolella,Bryan J. Song,Hasmik Keshishian,Steven A. Carr,Jen Q. Pan,Morgan Sheng
DOI: https://doi.org/10.1101/2024.10.10.617460
2024-10-12
Abstract:Rare loss-of-function (LoF) variants in , which encodes the SRRM2 splicing factor, are associated with schizophrenia and a neurodevelopmental disorder. How haploinsufficiency of leads to brain dysfunction is unknown. We find that mice display (i) large-scale changes in gene expression in neuronal and glial cells, affecting synapse-related and other common molecular pathways across multiple brain regions, (ii) reduction of multiple key postsynaptic proteins, including the gamma isoform of SynGAP, itself encoded by a neurodevelopmental disorder risk gene, (iii) abnormal splicing and elevated expression of Agap3, a SynGAP interactor, (iv) reduced numbers of oligodendrocytes accompanied by decreased expression of myelin-related mRNAs and proteins, and (v) behavioral and EEG abnormalities, including reduction in sleep spindles that phenocopy humans with schizophrenia. Our findings provide insights into the molecular and neurobiological mechanisms of and potential therapeutic avenues for schizophrenia and the LoF neurodevelopmental disorder.
Neuroscience
What problem does this paper attempt to address?